top of page
Drug Development in NMIBC from Scientific, Regulatory, Clinician, and Patient Perspectives (2021)
AUA
3/5/21, 6:00 PM
America/New York GMT -4 summer
Description
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Sarah Psutka
Opening Remarks, Recap from Previous Day, and Goal Setting, SESSION TWO: Clinical Dilemmas in Management of NMIBC, Trial Design Considerations for Intermediate Risk NMIBC, The Natural History of High Risk NMIBC: Novel Therapies versus Cystectomy, Sequential Therapy in BCG Unresponsive Disease, Discussion, Q&A, Keynote: The Science of Combination Therapy, Keynote: Racial Disparities in Cancer Clinical Trials, Closing Remarks
Inglês
Description
Speakers
Matthew Galsky, Yair Lotan, Trinity Bivalacqua, Angela Smith, Sima Porten, Adam Palmer, Otis Webb Brawley
Speakers
Link to Event
Banner
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.
Registro
bottom of page